中国药师
中國藥師
중국약사
China Pharmacist
2015年
10期
1760-1762
,共3页
药学服务%慢性阻塞性肺疾病%CAT评分%mMRC分级
藥學服務%慢性阻塞性肺疾病%CAT評分%mMRC分級
약학복무%만성조새성폐질병%CAT평분%mMRC분급
Pharmaceutical care%Chronic obstructive pulmonary disease%CAT score%mMRC Classification
目的:探讨临床药师开展药学服务对老年慢性阻塞性肺疾病( COPD)患者临床疗效的影响. 方法: COPD患者192例随机分为试验组(n=100)和对照组(n=92). 对照组患者给予常规治疗,不施加其他干预措施. 试验组在对照组基础上,临床药师开展药学服务. 比较两组患者入院和出院时COPD评估测试( COPD assessment test, CAT)评分、改良英国医学研究理事会呼吸困难指数( modified British medical research council, mMRC)分级、肺功能指标( FEV1%). 结果:两组患者出院时, CAT评分、mMRC分级均较入院时降低,而 FEV1%预计值升高(P <0.05);且试验组患者出院时 CAT 评分、mMRC 分级、FEV1%预计值等指标均优于对照组(P<0. 05). 试验组患者出现药物差错和药品不良反应率明显低于对照组. 结论: 临床药师对老年COPD 患者开展药学服务,有助于患者病情康复.
目的:探討臨床藥師開展藥學服務對老年慢性阻塞性肺疾病( COPD)患者臨床療效的影響. 方法: COPD患者192例隨機分為試驗組(n=100)和對照組(n=92). 對照組患者給予常規治療,不施加其他榦預措施. 試驗組在對照組基礎上,臨床藥師開展藥學服務. 比較兩組患者入院和齣院時COPD評估測試( COPD assessment test, CAT)評分、改良英國醫學研究理事會呼吸睏難指數( modified British medical research council, mMRC)分級、肺功能指標( FEV1%). 結果:兩組患者齣院時, CAT評分、mMRC分級均較入院時降低,而 FEV1%預計值升高(P <0.05);且試驗組患者齣院時 CAT 評分、mMRC 分級、FEV1%預計值等指標均優于對照組(P<0. 05). 試驗組患者齣現藥物差錯和藥品不良反應率明顯低于對照組. 結論: 臨床藥師對老年COPD 患者開展藥學服務,有助于患者病情康複.
목적:탐토림상약사개전약학복무대노년만성조새성폐질병( COPD)환자림상료효적영향. 방법: COPD환자192례수궤분위시험조(n=100)화대조조(n=92). 대조조환자급여상규치료,불시가기타간예조시. 시험조재대조조기출상,림상약사개전약학복무. 비교량조환자입원화출원시COPD평고측시( COPD assessment test, CAT)평분、개량영국의학연구리사회호흡곤난지수( modified British medical research council, mMRC)분급、폐공능지표( FEV1%). 결과:량조환자출원시, CAT평분、mMRC분급균교입원시강저,이 FEV1%예계치승고(P <0.05);차시험조환자출원시 CAT 평분、mMRC 분급、FEV1%예계치등지표균우우대조조(P<0. 05). 시험조환자출현약물차착화약품불량반응솔명현저우대조조. 결론: 림상약사대노년COPD 환자개전약학복무,유조우환자병정강복.
Objective:To discuss the therapeutic effect of pharmaceutical care for old patients with chronic obstructive pulmonary disease ( COPD) . Methods:Totally 192 patients diagnosed as COPD were randomly divided into 2 groups according to a random num-ber table, 100 cases in the experimental group and 92 cases in the control group. The control group was treated with the conditional therapy, and the experimental group was treated with pharmaceutical care additionally. The studieds on COPD assessment test ( CAT) , modified British medical research council ( mMRC) and the value of pulmonary function index ( FEV1% index) were carried out and compared between the two groups. Results:There was no statistically significant difference in the CAT score, mMRC classification and FEV1% index between the two groups on admission (P>0. 05), however, after the treatment, the CAT score and mMRC classifica-tion were decreased and FEV1% index was increased in the two groups, and there was statistical significance between them ( P <0. 05). The CAT score and mMRC classification in the experimental group were lower and FEV1% index was higher than that in the control group(P<0.05). Compared with the medication errors(n=13, 14.13%) and incidence of adverse drug reactions(n=5, 5. 43%) in the control group, the medication errors(n=2, 2. 0%) and incidence of adverse drug reactions (0%) in the experimental group were significantly decreased. Conclusion:Clinical pharmacists provide effectively pharmaceutical care, which can significantly improve the clinical therapeutic efficacy in old patients with COPD.
